[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Urine in Vitro Diagnostics Supply, Demand and Key Producers, 2024-2030

March 2024 | 159 pages | ID: GF5CA5BF7B5DEN
GlobalInfoResearch

US$ 4,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global Urine in Vitro Diagnostics market size is expected to reach $ 34280 million by 2030, rising at a market growth of 5.7% CAGR during the forecast period (2024-2030).

The Urine In Vitro Diagnostics market is driven by the essential role urine analysis plays in assessing various health conditions. In vitro diagnostic devices dedicated to urine testing, such as urinalysis strips, urine chemistry analyzers, and automated urine sediment analyzers, are instrumental in detecting disorders related to the urinary system, diabetes, kidney diseases, and metabolic conditions. The market benefits from the increasing prevalence of such health issues and the need for efficient and cost-effective diagnostic solutions. The simplicity and non-invasiveness of urine sample collection contribute to the widespread adoption of urine in vitro diagnostics, making it a fundamental component of routine medical examinations and disease management.

Urine in vitro diagnostics (IVD) involve the analysis of urine samples to obtain information about various aspects of an individual's health. Urine is a valuable biological fluid that can provide insights into kidney function, metabolic processes, and the presence of certain substances or markers.

This report studies the global Urine in Vitro Diagnostics demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Urine in Vitro Diagnostics, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Urine in Vitro Diagnostics that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global Urine in Vitro Diagnostics total market, 2019-2030, (USD Million)

Global Urine in Vitro Diagnostics total market by region & country, CAGR, 2019-2030, (USD Million)

U.S. VS China: Urine in Vitro Diagnostics total market, key domestic companies and share, (USD Million)

Global Urine in Vitro Diagnostics revenue by player and market share 2019-2024, (USD Million)

Global Urine in Vitro Diagnostics total market by Type, CAGR, 2019-2030, (USD Million)

Global Urine in Vitro Diagnostics total market by Application, CAGR, 2019-2030, (USD Million).

This reports profiles major players in the global Urine in Vitro Diagnostics market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Siemens, Abbott, Danaher, Thermo Fisher, BioMerieux, Bio-Rad, BD and KHB, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Urine in Vitro Diagnostics market.

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Urine in Vitro Diagnostics Market, By Region:
  • United States
  • China
  • Europe
  • Japan
  • South Korea
  • ASEAN
  • India
  • Rest of World
Global Urine in Vitro Diagnostics Market, Segmentation by Type
  • Consumables
  • Equipment
Global Urine in Vitro Diagnostics Market, Segmentation by Application
  • Drug Testing
  • Infectious Disease Testing
  • Other
Companies Profiled:
  • Roche
  • Siemens
  • Abbott
  • Danaher
  • Thermo Fisher
  • BioMerieux
  • Bio-Rad
  • BD
  • KHB
  • Daan Gene
  • Leadman
  • Zhongsheng
  • Bsbe
  • Maccura
  • Hitachi
  • Canon
  • Sysmex
  • Auto Bio
  • Mindray
  • Bgi
  • Wondfo
Key Questions Answered

1. How big is the global Urine in Vitro Diagnostics market?

2. What is the demand of the global Urine in Vitro Diagnostics market?

3. What is the year over year growth of the global Urine in Vitro Diagnostics market?

4. What is the total value of the global Urine in Vitro Diagnostics market?

5. Who are the major players in the global Urine in Vitro Diagnostics market?
1 SUPPLY SUMMARY

1.1 Urine in Vitro Diagnostics Introduction
1.2 World Urine in Vitro Diagnostics Market Size & Forecast (2019 & 2023 & 2030)
1.3 World Urine in Vitro Diagnostics Total Market by Region (by Headquarter Location)
  1.3.1 World Urine in Vitro Diagnostics Market Size by Region (2019-2030), (by Headquarter Location)
  1.3.2 United States Urine in Vitro Diagnostics Market Size (2019-2030)
  1.3.3 China Urine in Vitro Diagnostics Market Size (2019-2030)
  1.3.4 Europe Urine in Vitro Diagnostics Market Size (2019-2030)
  1.3.5 Japan Urine in Vitro Diagnostics Market Size (2019-2030)
  1.3.6 South Korea Urine in Vitro Diagnostics Market Size (2019-2030)
  1.3.7 ASEAN Urine in Vitro Diagnostics Market Size (2019-2030)
  1.3.8 India Urine in Vitro Diagnostics Market Size (2019-2030)
1.4 Market Drivers, Restraints and Trends
  1.4.1 Urine in Vitro Diagnostics Market Drivers
  1.4.2 Factors Affecting Demand
  1.4.3 Urine in Vitro Diagnostics Major Market Trends

2 DEMAND SUMMARY

2.1 World Urine in Vitro Diagnostics Consumption Value (2019-2030)
2.2 World Urine in Vitro Diagnostics Consumption Value by Region
  2.2.1 World Urine in Vitro Diagnostics Consumption Value by Region (2019-2024)
  2.2.2 World Urine in Vitro Diagnostics Consumption Value Forecast by Region (2025-2030)
2.3 United States Urine in Vitro Diagnostics Consumption Value (2019-2030)
2.4 China Urine in Vitro Diagnostics Consumption Value (2019-2030)
2.5 Europe Urine in Vitro Diagnostics Consumption Value (2019-2030)
2.6 Japan Urine in Vitro Diagnostics Consumption Value (2019-2030)
2.7 South Korea Urine in Vitro Diagnostics Consumption Value (2019-2030)
2.8 ASEAN Urine in Vitro Diagnostics Consumption Value (2019-2030)
2.9 India Urine in Vitro Diagnostics Consumption Value (2019-2030)

3 WORLD URINE IN VITRO DIAGNOSTICS COMPANIES COMPETITIVE ANALYSIS

3.1 World Urine in Vitro Diagnostics Revenue by Player (2019-2024)
3.2 Industry Rank and Concentration Rate (CR)
  3.2.1 Global Urine in Vitro Diagnostics Industry Rank of Major Players
  3.2.2 Global Concentration Ratios (CR4) for Urine in Vitro Diagnostics in 2023
  3.2.3 Global Concentration Ratios (CR8) for Urine in Vitro Diagnostics in 2023
3.3 Urine in Vitro Diagnostics Company Evaluation Quadrant
3.4 Urine in Vitro Diagnostics Market: Overall Company Footprint Analysis
  3.4.1 Urine in Vitro Diagnostics Market: Region Footprint
  3.4.2 Urine in Vitro Diagnostics Market: Company Product Type Footprint
  3.4.3 Urine in Vitro Diagnostics Market: Company Product Application Footprint
3.5 Competitive Environment
  3.5.1 Historical Structure of the Industry
  3.5.2 Barriers of Market Entry
  3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity

4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)

4.1 United States VS China: Urine in Vitro Diagnostics Revenue Comparison (by Headquarter Location)
  4.1.1 United States VS China: Urine in Vitro Diagnostics Market Size Comparison (2019 & 2023 & 2030) (by Headquarter Location)
  4.1.2 United States VS China: Urine in Vitro Diagnostics Revenue Market Share Comparison (2019 & 2023 & 2030)
4.2 United States Based Companies VS China Based Companies: Urine in Vitro Diagnostics Consumption Value Comparison
  4.2.1 United States VS China: Urine in Vitro Diagnostics Consumption Value Comparison (2019 & 2023 & 2030)
  4.2.2 United States VS China: Urine in Vitro Diagnostics Consumption Value Market Share Comparison (2019 & 2023 & 2030)
4.3 United States Based Urine in Vitro Diagnostics Companies and Market Share, 2019-2024
  4.3.1 United States Based Urine in Vitro Diagnostics Companies, Headquarters (States, Country)
  4.3.2 United States Based Companies Urine in Vitro Diagnostics Revenue, (2019-2024)
4.4 China Based Companies Urine in Vitro Diagnostics Revenue and Market Share, 2019-2024
  4.4.1 China Based Urine in Vitro Diagnostics Companies, Company Headquarters (Province, Country)
  4.4.2 China Based Companies Urine in Vitro Diagnostics Revenue, (2019-2024)
4.5 Rest of World Based Urine in Vitro Diagnostics Companies and Market Share, 2019-2024
  4.5.1 Rest of World Based Urine in Vitro Diagnostics Companies, Headquarters (States, Country)
  4.5.2 Rest of World Based Companies Urine in Vitro Diagnostics Revenue, (2019-2024)

5 MARKET ANALYSIS BY TYPE

5.1 World Urine in Vitro Diagnostics Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
  5.2.1 Consumables
  5.2.2 Equipment
5.3 Market Segment by Type
  5.3.1 World Urine in Vitro Diagnostics Market Size by Type (2019-2024)
  5.3.2 World Urine in Vitro Diagnostics Market Size by Type (2025-2030)
  5.3.3 World Urine in Vitro Diagnostics Market Size Market Share by Type (2019-2030)

6 MARKET ANALYSIS BY APPLICATION

6.1 World Urine in Vitro Diagnostics Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
  6.2.1 Drug Testing
  6.2.2 Infectious Disease Testing
  6.2.3 Other
6.3 Market Segment by Application
  6.3.1 World Urine in Vitro Diagnostics Market Size by Application (2019-2024)
  6.3.2 World Urine in Vitro Diagnostics Market Size by Application (2025-2030)
  6.3.3 World Urine in Vitro Diagnostics Market Size by Application (2019-2030)

7 COMPANY PROFILES

7.1 Roche
  7.1.1 Roche Details
  7.1.2 Roche Major Business
  7.1.3 Roche Urine in Vitro Diagnostics Product and Services
  7.1.4 Roche Urine in Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
  7.1.5 Roche Recent Developments/Updates
  7.1.6 Roche Competitive Strengths & Weaknesses
7.2 Siemens
  7.2.1 Siemens Details
  7.2.2 Siemens Major Business
  7.2.3 Siemens Urine in Vitro Diagnostics Product and Services
  7.2.4 Siemens Urine in Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
  7.2.5 Siemens Recent Developments/Updates
  7.2.6 Siemens Competitive Strengths & Weaknesses
7.3 Abbott
  7.3.1 Abbott Details
  7.3.2 Abbott Major Business
  7.3.3 Abbott Urine in Vitro Diagnostics Product and Services
  7.3.4 Abbott Urine in Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
  7.3.5 Abbott Recent Developments/Updates
  7.3.6 Abbott Competitive Strengths & Weaknesses
7.4 Danaher
  7.4.1 Danaher Details
  7.4.2 Danaher Major Business
  7.4.3 Danaher Urine in Vitro Diagnostics Product and Services
  7.4.4 Danaher Urine in Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
  7.4.5 Danaher Recent Developments/Updates
  7.4.6 Danaher Competitive Strengths & Weaknesses
7.5 Thermo Fisher
  7.5.1 Thermo Fisher Details
  7.5.2 Thermo Fisher Major Business
  7.5.3 Thermo Fisher Urine in Vitro Diagnostics Product and Services
  7.5.4 Thermo Fisher Urine in Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
  7.5.5 Thermo Fisher Recent Developments/Updates
  7.5.6 Thermo Fisher Competitive Strengths & Weaknesses
7.6 BioMerieux
  7.6.1 BioMerieux Details
  7.6.2 BioMerieux Major Business
  7.6.3 BioMerieux Urine in Vitro Diagnostics Product and Services
  7.6.4 BioMerieux Urine in Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
  7.6.5 BioMerieux Recent Developments/Updates
  7.6.6 BioMerieux Competitive Strengths & Weaknesses
7.7 Bio-Rad
  7.7.1 Bio-Rad Details
  7.7.2 Bio-Rad Major Business
  7.7.3 Bio-Rad Urine in Vitro Diagnostics Product and Services
  7.7.4 Bio-Rad Urine in Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
  7.7.5 Bio-Rad Recent Developments/Updates
  7.7.6 Bio-Rad Competitive Strengths & Weaknesses
7.8 BD
  7.8.1 BD Details
  7.8.2 BD Major Business
  7.8.3 BD Urine in Vitro Diagnostics Product and Services
  7.8.4 BD Urine in Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
  7.8.5 BD Recent Developments/Updates
  7.8.6 BD Competitive Strengths & Weaknesses
7.9 KHB
  7.9.1 KHB Details
  7.9.2 KHB Major Business
  7.9.3 KHB Urine in Vitro Diagnostics Product and Services
  7.9.4 KHB Urine in Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
  7.9.5 KHB Recent Developments/Updates
  7.9.6 KHB Competitive Strengths & Weaknesses
7.10 Daan Gene
  7.10.1 Daan Gene Details
  7.10.2 Daan Gene Major Business
  7.10.3 Daan Gene Urine in Vitro Diagnostics Product and Services
  7.10.4 Daan Gene Urine in Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
  7.10.5 Daan Gene Recent Developments/Updates
  7.10.6 Daan Gene Competitive Strengths & Weaknesses
7.11 Leadman
  7.11.1 Leadman Details
  7.11.2 Leadman Major Business
  7.11.3 Leadman Urine in Vitro Diagnostics Product and Services
  7.11.4 Leadman Urine in Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
  7.11.5 Leadman Recent Developments/Updates
  7.11.6 Leadman Competitive Strengths & Weaknesses
7.12 Zhongsheng
  7.12.1 Zhongsheng Details
  7.12.2 Zhongsheng Major Business
  7.12.3 Zhongsheng Urine in Vitro Diagnostics Product and Services
  7.12.4 Zhongsheng Urine in Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
  7.12.5 Zhongsheng Recent Developments/Updates
  7.12.6 Zhongsheng Competitive Strengths & Weaknesses
7.13 Bsbe
  7.13.1 Bsbe Details
  7.13.2 Bsbe Major Business
  7.13.3 Bsbe Urine in Vitro Diagnostics Product and Services
  7.13.4 Bsbe Urine in Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
  7.13.5 Bsbe Recent Developments/Updates
  7.13.6 Bsbe Competitive Strengths & Weaknesses
7.14 Maccura
  7.14.1 Maccura Details
  7.14.2 Maccura Major Business
  7.14.3 Maccura Urine in Vitro Diagnostics Product and Services
  7.14.4 Maccura Urine in Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
  7.14.5 Maccura Recent Developments/Updates
  7.14.6 Maccura Competitive Strengths & Weaknesses
7.15 Hitachi
  7.15.1 Hitachi Details
  7.15.2 Hitachi Major Business
  7.15.3 Hitachi Urine in Vitro Diagnostics Product and Services
  7.15.4 Hitachi Urine in Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
  7.15.5 Hitachi Recent Developments/Updates
  7.15.6 Hitachi Competitive Strengths & Weaknesses
7.16 Canon
  7.16.1 Canon Details
  7.16.2 Canon Major Business
  7.16.3 Canon Urine in Vitro Diagnostics Product and Services
  7.16.4 Canon Urine in Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
  7.16.5 Canon Recent Developments/Updates
  7.16.6 Canon Competitive Strengths & Weaknesses
7.17 Sysmex
  7.17.1 Sysmex Details
  7.17.2 Sysmex Major Business
  7.17.3 Sysmex Urine in Vitro Diagnostics Product and Services
  7.17.4 Sysmex Urine in Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
  7.17.5 Sysmex Recent Developments/Updates
  7.17.6 Sysmex Competitive Strengths & Weaknesses
7.18 Auto Bio
  7.18.1 Auto Bio Details
  7.18.2 Auto Bio Major Business
  7.18.3 Auto Bio Urine in Vitro Diagnostics Product and Services
  7.18.4 Auto Bio Urine in Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
  7.18.5 Auto Bio Recent Developments/Updates
  7.18.6 Auto Bio Competitive Strengths & Weaknesses
7.19 Mindray
  7.19.1 Mindray Details
  7.19.2 Mindray Major Business
  7.19.3 Mindray Urine in Vitro Diagnostics Product and Services
  7.19.4 Mindray Urine in Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
  7.19.5 Mindray Recent Developments/Updates
  7.19.6 Mindray Competitive Strengths & Weaknesses
7.20 Bgi
  7.20.1 Bgi Details
  7.20.2 Bgi Major Business
  7.20.3 Bgi Urine in Vitro Diagnostics Product and Services
  7.20.4 Bgi Urine in Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
  7.20.5 Bgi Recent Developments/Updates
  7.20.6 Bgi Competitive Strengths & Weaknesses
7.21 Wondfo
  7.21.1 Wondfo Details
  7.21.2 Wondfo Major Business
  7.21.3 Wondfo Urine in Vitro Diagnostics Product and Services
  7.21.4 Wondfo Urine in Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
  7.21.5 Wondfo Recent Developments/Updates
  7.21.6 Wondfo Competitive Strengths & Weaknesses

8 INDUSTRY CHAIN ANALYSIS

8.1 Urine in Vitro Diagnostics Industry Chain
8.2 Urine in Vitro Diagnostics Upstream Analysis
8.3 Urine in Vitro Diagnostics Midstream Analysis
8.4 Urine in Vitro Diagnostics Downstream Analysis

9 RESEARCH FINDINGS AND CONCLUSION

10 APPENDIX

10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer

LIST OF TABLES

Table 1. World Urine in Vitro Diagnostics Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
Table 2. World Urine in Vitro Diagnostics Revenue by Region (2019-2024) & (USD Million), (by Headquarter Location)
Table 3. World Urine in Vitro Diagnostics Revenue by Region (2025-2030) & (USD Million), (by Headquarter Location)
Table 4. World Urine in Vitro Diagnostics Revenue Market Share by Region (2019-2024), (by Headquarter Location)
Table 5. World Urine in Vitro Diagnostics Revenue Market Share by Region (2025-2030), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Urine in Vitro Diagnostics Consumption Value Growth Rate Forecast by Region (2019 & 2023 & 2030) & (USD Million)
Table 8. World Urine in Vitro Diagnostics Consumption Value by Region (2019-2024) & (USD Million)
Table 9. World Urine in Vitro Diagnostics Consumption Value Forecast by Region (2025-2030) & (USD Million)
Table 10. World Urine in Vitro Diagnostics Revenue by Player (2019-2024) & (USD Million)
Table 11. Revenue Market Share of Key Urine in Vitro Diagnostics Players in 2023
Table 12. World Urine in Vitro Diagnostics Industry Rank of Major Player, Based on Revenue in 2023
Table 13. Global Urine in Vitro Diagnostics Company Evaluation Quadrant
Table 14. Head Office of Key Urine in Vitro Diagnostics Player
Table 15. Urine in Vitro Diagnostics Market: Company Product Type Footprint
Table 16. Urine in Vitro Diagnostics Market: Company Product Application Footprint
Table 17. Urine in Vitro Diagnostics Mergers & Acquisitions Activity
Table 18. United States VS China Urine in Vitro Diagnostics Market Size Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 19. United States VS China Urine in Vitro Diagnostics Consumption Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 20. United States Based Urine in Vitro Diagnostics Companies, Headquarters (States, Country)
Table 21. United States Based Companies Urine in Vitro Diagnostics Revenue, (2019-2024) & (USD Million)
Table 22. United States Based Companies Urine in Vitro Diagnostics Revenue Market Share (2019-2024)
Table 23. China Based Urine in Vitro Diagnostics Companies, Headquarters (Province, Country)
Table 24. China Based Companies Urine in Vitro Diagnostics Revenue, (2019-2024) & (USD Million)
Table 25. China Based Companies Urine in Vitro Diagnostics Revenue Market Share (2019-2024)
Table 26. Rest of World Based Urine in Vitro Diagnostics Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Urine in Vitro Diagnostics Revenue, (2019-2024) & (USD Million)
Table 28. Rest of World Based Companies Urine in Vitro Diagnostics Revenue Market Share (2019-2024)
Table 29. World Urine in Vitro Diagnostics Market Size by Type, (USD Million), 2019 & 2023 & 2030
Table 30. World Urine in Vitro Diagnostics Market Size by Type (2019-2024) & (USD Million)
Table 31. World Urine in Vitro Diagnostics Market Size by Type (2025-2030) & (USD Million)
Table 32. World Urine in Vitro Diagnostics Market Size by Application, (USD Million), 2019 & 2023 & 2030
Table 33. World Urine in Vitro Diagnostics Market Size by Application (2019-2024) & (USD Million)
Table 34. World Urine in Vitro Diagnostics Market Size by Application (2025-2030) & (USD Million)
Table 35. Roche Basic Information, Area Served and Competitors
Table 36. Roche Major Business
Table 37. Roche Urine in Vitro Diagnostics Product and Services
Table 38. Roche Urine in Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 39. Roche Recent Developments/Updates
Table 40. Roche Competitive Strengths & Weaknesses
Table 41. Siemens Basic Information, Area Served and Competitors
Table 42. Siemens Major Business
Table 43. Siemens Urine in Vitro Diagnostics Product and Services
Table 44. Siemens Urine in Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 45. Siemens Recent Developments/Updates
Table 46. Siemens Competitive Strengths & Weaknesses
Table 47. Abbott Basic Information, Area Served and Competitors
Table 48. Abbott Major Business
Table 49. Abbott Urine in Vitro Diagnostics Product and Services
Table 50. Abbott Urine in Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 51. Abbott Recent Developments/Updates
Table 52. Abbott Competitive Strengths & Weaknesses
Table 53. Danaher Basic Information, Area Served and Competitors
Table 54. Danaher Major Business
Table 55. Danaher Urine in Vitro Diagnostics Product and Services
Table 56. Danaher Urine in Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 57. Danaher Recent Developments/Updates
Table 58. Danaher Competitive Strengths & Weaknesses
Table 59. Thermo Fisher Basic Information, Area Served and Competitors
Table 60. Thermo Fisher Major Business
Table 61. Thermo Fisher Urine in Vitro Diagnostics Product and Services
Table 62. Thermo Fisher Urine in Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 63. Thermo Fisher Recent Developments/Updates
Table 64. Thermo Fisher Competitive Strengths & Weaknesses
Table 65. BioMerieux Basic Information, Area Served and Competitors
Table 66. BioMerieux Major Business
Table 67. BioMerieux Urine in Vitro Diagnostics Product and Services
Table 68. BioMerieux Urine in Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 69. BioMerieux Recent Developments/Updates
Table 70. BioMerieux Competitive Strengths & Weaknesses
Table 71. Bio-Rad Basic Information, Area Served and Competitors
Table 72. Bio-Rad Major Business
Table 73. Bio-Rad Urine in Vitro Diagnostics Product and Services
Table 74. Bio-Rad Urine in Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 75. Bio-Rad Recent Developments/Updates
Table 76. Bio-Rad Competitive Strengths & Weaknesses
Table 77. BD Basic Information, Area Served and Competitors
Table 78. BD Major Business
Table 79. BD Urine in Vitro Diagnostics Product and Services
Table 80. BD Urine in Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 81. BD Recent Developments/Updates
Table 82. BD Competitive Strengths & Weaknesses
Table 83. KHB Basic Information, Area Served and Competitors
Table 84. KHB Major Business
Table 85. KHB Urine in Vitro Diagnostics Product and Services
Table 86. KHB Urine in Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 87. KHB Recent Developments/Updates
Table 88. KHB Competitive Strengths & Weaknesses
Table 89. Daan Gene Basic Information, Area Served and Competitors
Table 90. Daan Gene Major Business
Table 91. Daan Gene Urine in Vitro Diagnostics Product and Services
Table 92. Daan Gene Urine in Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 93. Daan Gene Recent Developments/Updates
Table 94. Daan Gene Competitive Strengths & Weaknesses
Table 95. Leadman Basic Information, Area Served and Competitors
Table 96. Leadman Major Business
Table 97. Leadman Urine in Vitro Diagnostics Product and Services
Table 98. Leadman Urine in Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 99. Leadman Recent Developments/Updates
Table 100. Leadman Competitive Strengths & Weaknesses
Table 101. Zhongsheng Basic Information, Area Served and Competitors
Table 102. Zhongsheng Major Business
Table 103. Zhongsheng Urine in Vitro Diagnostics Product and Services
Table 104. Zhongsheng Urine in Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 105. Zhongsheng Recent Developments/Updates
Table 106. Zhongsheng Competitive Strengths & Weaknesses
Table 107. Bsbe Basic Information, Area Served and Competitors
Table 108. Bsbe Major Business
Table 109. Bsbe Urine in Vitro Diagnostics Product and Services
Table 110. Bsbe Urine in Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 111. Bsbe Recent Developments/Updates
Table 112. Bsbe Competitive Strengths & Weaknesses
Table 113. Maccura Basic Information, Area Served and Competitors
Table 114. Maccura Major Business
Table 115. Maccura Urine in Vitro Diagnostics Product and Services
Table 116. Maccura Urine in Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 117. Maccura Recent Developments/Updates
Table 118. Maccura Competitive Strengths & Weaknesses
Table 119. Hitachi Basic Information, Area Served and Competitors
Table 120. Hitachi Major Business
Table 121. Hitachi Urine in Vitro Diagnostics Product and Services
Table 122. Hitachi Urine in Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 123. Hitachi Recent Developments/Updates
Table 124. Hitachi Competitive Strengths & Weaknesses
Table 125. Canon Basic Information, Area Served and Competitors
Table 126. Canon Major Business
Table 127. Canon Urine in Vitro Diagnostics Product and Services
Table 128. Canon Urine in Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 129. Canon Recent Developments/Updates
Table 130. Canon Competitive Strengths & Weaknesses
Table 131. Sysmex Basic Information, Area Served and Competitors
Table 132. Sysmex Major Business
Table 133. Sysmex Urine in Vitro Diagnostics Product and Services
Table 134. Sysmex Urine in Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 135. Sysmex Recent Developments/Updates
Table 136. Sysmex Competitive Strengths & Weaknesses
Table 137. Auto Bio Basic Information, Area Served and Competitors
Table 138. Auto Bio Major Business
Table 139. Auto Bio Urine in Vitro Diagnostics Product and Services
Table 140. Auto Bio Urine in Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 141. Auto Bio Recent Developments/Updates
Table 142. Auto Bio Competitive Strengths & Weaknesses
Table 143. Mindray Basic Information, Area Served and Competitors
Table 144. Mindray Major Business
Table 145. Mindray Urine in Vitro Diagnostics Product and Services
Table 146. Mindray Urine in Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 147. Mindray Recent Developments/Updates
Table 148. Mindray Competitive Strengths & Weaknesses
Table 149. Bgi Basic Information, Area Served and Competitors
Table 150. Bgi Major Business
Table 151. Bgi Urine in Vitro Diagnostics Product and Services
Table 152. Bgi Urine in Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 153. Bgi Recent Developments/Updates
Table 154. Wondfo Basic Information, Area Served and Competitors
Table 155. Wondfo Major Business
Table 156. Wondfo Urine in Vitro Diagnostics Product and Services
Table 157. Wondfo Urine in Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 158. Global Key Players of Urine in Vitro Diagnostics Upstream (Raw Materials)
Table 159. Urine in Vitro Diagnostics Typical Customers

LIST OF FIGURE

Figure 1. Urine in Vitro Diagnostics Picture
Figure 2. World Urine in Vitro Diagnostics Total Market Size: 2019 & 2023 & 2030, (USD Million)
Figure 3. World Urine in Vitro Diagnostics Total Market Size (2019-2030) & (USD Million)
Figure 4. World Urine in Vitro Diagnostics Revenue Market Share by Region (2019, 2023 and 2030) & (USD Million) , (by Headquarter Location)
Figure 5. World Urine in Vitro Diagnostics Revenue Market Share by Region (2019-2030), (by Headquarter Location)
Figure 6. United States Based Company Urine in Vitro Diagnostics Revenue (2019-2030) & (USD Million)
Figure 7. China Based Company Urine in Vitro Diagnostics Revenue (2019-2030) & (USD Million)
Figure 8. Europe Based Company Urine in Vitro Diagnostics Revenue (2019-2030) & (USD Million)
Figure 9. Japan Based Company Urine in Vitro Diagnostics Revenue (2019-2030) & (USD Million)
Figure 10. South Korea Based Company Urine in Vitro Diagnostics Revenue (2019-2030) & (USD Million)
Figure 11. ASEAN Based Company Urine in Vitro Diagnostics Revenue (2019-2030) & (USD Million)
Figure 12. India Based Company Urine in Vitro Diagnostics Revenue (2019-2030) & (USD Million)
Figure 13. Urine in Vitro Diagnostics Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Urine in Vitro Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 16. World Urine in Vitro Diagnostics Consumption Value Market Share by Region (2019-2030)
Figure 17. United States Urine in Vitro Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 18. China Urine in Vitro Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 19. Europe Urine in Vitro Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 20. Japan Urine in Vitro Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 21. South Korea Urine in Vitro Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 22. ASEAN Urine in Vitro Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 23. India Urine in Vitro Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 24. Producer Shipments of Urine in Vitro Diagnostics by Player Revenue ($MM) and Market Share (%): 2023
Figure 25. Global Four-firm Concentration Ratios (CR4) for Urine in Vitro Diagnostics Markets in 2023
Figure 26. Global Four-firm Concentration Ratios (CR8) for Urine in Vitro Diagnostics Markets in 2023
Figure 27. United States VS China: Urine in Vitro Diagnostics Revenue Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: Urine in Vitro Diagnostics Consumption Value Market Share Comparison (2019 & 2023 & 2030)
Figure 29. World Urine in Vitro Diagnostics Market Size by Type, (USD Million), 2019 & 2023 & 2030
Figure 30. World Urine in Vitro Diagnostics Market Size Market Share by Type in 2023
Figure 31. Consumables
Figure 32. Equipment
Figure 33. World Urine in Vitro Diagnostics Market Size Market Share by Type (2019-2030)
Figure 34. World Urine in Vitro Diagnostics Market Size by Application, (USD Million), 2019 & 2023 & 2030
Figure 35. World Urine in Vitro Diagnostics Market Size Market Share by Application in 2023
Figure 36. Drug Testing
Figure 37. Infectious Disease Testing
Figure 38. Other
Figure 39. Urine in Vitro Diagnostics Industrial Chain
Figure 40. Methodology
Figure 41. Research Process and Data Source


More Publications